Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed May 20, 2015
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Award
Stock Option (right to buy)
2015-05-18+10,000→ 10,000 totalExercise: $8.20Exp: 2025-05-17→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 18, 2015. This option vests in four equal annual installments over a four-year period from the date of grant.